Wayne Foster
CIK 1709769 · EVP, Chief Accounting Officer · last filed 2026-02-03
Wayne Foster is an EVP, Chief Accounting Officer who has filed 10 SEC Form 4 insider transactions across 2 companies since 2018. The most recent filing, for AVIR, was dated Feb 3, 2026. Across all open-market trades the lifetime net is −$47.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $356.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$356.2K
2
10
-$47.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AVIR | EVP, Chief Accounting Officer | 79,329 | $4.49 | $356.2K | -$47.9K | 7 | 2026-02-03 |
| Mersana Therapeutics, Inc. (MRSN) Delisted | Vice President of Finance | 65,322 | $29.08 | $1.90M | $0 | 3 | 2019-01-25 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-03 | AVIR | Mixed | +29,201 | -$51.4K | EDGAR |
| 2025-02-04 | AVIR | Mixed | +29,271 | -$36.9K | EDGAR |
| 2024-02-02 | AVIR | Mixed | +20,857 | -$47.9K | EDGAR |
| 2023-02-02 | AVIR | Grant (A) | — | $0 | EDGAR |
| 2022-02-02 | AVIR | Grant (A) | — | $0 | EDGAR |
| 2021-02-01 | AVIR | Grant (A) | — | $0 | EDGAR |
| 2020-10-30 | AVIR | Grant (A) | — | $0 | EDGAR |
| 2019-01-25 | Mersana Therapeutics, Inc. (MRSN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-02-06 | Mersana Therapeutics, Inc. (MRSN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-02-01 | Mersana Therapeutics, Inc. (MRSN) Delisted | Exer (M) | +14,705 | $44.6K | EDGAR |